Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion type Assertion NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_head.
- NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion description "[Our results showed that decreased expression levels of PER1, PER2, PER3, CRY2, and TIM in hepatocellular carcinomas were observed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_provenance.
- NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion evidence source_evidence_literature NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_provenance.
- NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion SIO_000772 18444243 NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_provenance.
- NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion wasDerivedFrom befree-20140225 NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_provenance.
- NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_assertion wasGeneratedBy ECO_0000203 NP546616.RAWA6tGPc2SeuBogs-YTM1aBElKlkYsPlafoFpOt_wgRE130_provenance.